age
Item
age≥18y
boolean
C0001779 (UMLS CUI [1])
karnofsky
Item
kps≥ 70
boolean
C0206065 (UMLS CUI [1])
breast cancer
Item
pathologic diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
measurable lesion
Item
at least 1 measurable lesion as defined by modified recist criteria
boolean
C1513041 (UMLS CUI [1])
laboratory values
Item
screening laboratory values with the following parameters: hemoglobin:≥10.0 g/dl absolute neutrophils count:≥1.5×109/l platelet:≥100×109/l creatinine clearance rate:
boolean
C0019046 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
lab results
Item
≥60ml/min total bilirubin: ≤1.5 ×upper limits of normal alkaline phosphatase,aspartate aminotransferase and alanine aminotransferase:≤ 2.5×upper limits of normal(≤5×upper limits of normal if liver metastasis are present)
boolean
C0201913 (UMLS CUI [1])
C0002059 (UMLS CUI [2])
informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
negative pregnancy test
Item
for women of child bearing potential,a negative serum or urine pregnancy test result before study entry.
boolean
C0427780 (UMLS CUI [1])
chemotherapy treatment
Item
more than 2 cytotoxic chemotherapy treatment regimens for metastatic disease.
boolean
C3665472 (UMLS CUI [1])
5-fluorouracil
Item
prior exposure to 5-fluorouracil continuous infusion.
boolean
C0016360 (UMLS CUI [1])
docetaxol for metastatic disease
Item
prior exposure docetaxol for metastatic disease
boolean
C0246415 (UMLS CUI [1])
cancer
Item
any other cancer within 5 years prior to screening with the exception of contralateral breast cancer,adequately treated cervical carcinoma in situ,or adequately treated basal or squamous cell carcinoma of skin
boolean
C0006826 (UMLS CUI [1])